Status | Study |
Enrolling by invitation |
Study Name: Dose Finding Trial of ARQ 092 in Children and Adults With Proteus Syndrome Condition: Proteus Syndrome Date: 2015-10-31 Interventions: Drug: ARQ 092 |
Recruiting |
Study Name: Genetic Heterogeneity and Genotype-phenotype Correlation of Children and Adults With Tuberous Sclerosis Complex Condition: Sclerosis Tuberosa Tuberous Sclerosis Complex Cerebral Scl Date: 2015-10-13 |
Recruiting |
Study Name: Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations Condition: PTEN ASD Autism Macrocep Date: 2015-05-11 |
Recruiting |
Study Name: A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD Condition: Epilepsy Tuberous Sclerosis Complex Focal Cortical Dysplas Date: 2014-10-08 Interventions: Drug: Everolimus This study will measure if the drug called Everolimus effects mTOR signaling (an electr |
Active, not recruiting |
Study Name: A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas Condition: Basal Cell Carcinoma Date: 2013-03-19 Interventions: Drug: Vismodegib Vismodegib 15 |
Completed |
Study Name: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas Condition: Basal Cell Nevus Syndrome Gorlin's Syndrome Date: 2012-03-14 Interventions: Drug: Vismodegib 150 mg per da |
Completed |
Study Name: Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants Condition: Coronary Artery Disease Proteus Syndrome Coffin - Sins Syn Date: 2011-06-08 |
Recruiting |
Study Name: DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study Condition: Pleuropulmonary Blastoma Cystic Nephroma Ovarian Sertoli-L Date: 2010-11-23 |
Completed |
Study Name: Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes Condition: Cowden's Disease Hamartoma Syndrome, Multiple Date: 2009-09-03 Interventions: Radiation: fludeoxyglucose F 18 |
Completed |
Study Name: A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer Condition: Breast Cancer Advanced Solid Tumors Cowden Syndrome Date: 2008-02-08 Interventions: Drug: BEZ235 |